Alzheimer’s disease: Insights from epidemiology
Tóm tắt
Từ khóa
Tài liệu tham khảo
Jorm A.F., Korten A.E., Henderson A.S.: The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr. Scand. 76: 465–479, 1987.
Gao S., Hendrie H.C., Hall K.S., Hui S.: The relationship between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch. Gen. Psychiatry 55: 809–815, 1998.
Robertson A.: The politics of Alzheimer’s disease: a case study in apocalyptic demography. Int. J. Health Serv. 20: 429–442, 1990.
McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M.: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34: 939–944, 1984.
Erkinjuntti T., Østbye T., Steenhuis R.E., Hachinski V.: The effect of different diagnostic criteria on the prevalence of dementia. N. Engl. J. Med. 337: 1667–1674, 1997.
Hy L.X., Keller D.M.: Prevalence of AD among whites: a summary by levels of severity. Neurology 55: 198–204, 2000.
Andersen K., Nielsen H., Lolk A., Andersen J.T., Becker I., Kragh-Sörensen P.: Incidence of very mild to severe dementia and Alzheimer’s disease in Denmark: the Odense Study. Neurology 52: 85–90, 1999.
Breteler M.M.B.: Vascular involvement in cognitive decline and dementia: epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. Ann. N.Y. Acad. Sci. 903: 457–465, 2000.
Di Iorio A., Zito M., Lupinetti M., Abate G.: Are vascular factors involved in Alzheimer’s disease? Facts and theories. Aging Clin. Exp. Res. 11: 345–352, 1999.
Breteler M.M.B., Claus J.J., van Duijn C.M., Launer L.J., Hofman A.: Epidemiology of Alzheimer’s disease. Epidemiol. Rev. 14: 59–82, 1992.
Hofman A., Rocca W.A., Brayne C., Breteler M.M., Clarke M., Cooper B., Copeland J.R., Dartigues J-F., da Silva Droux A., Hagnell O.: The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. EURODEM Prevalence Research Group. Int. J. Epidemiol. 20: 736–748, 1991.
Rocca W.A., Hofman A., Brayne C., Breteler M.M., Clarke M., Copeland J.R., Dartigues J-F., Engedal K., Hagnell O., Heeren T.J.: Frequency and distribution of Alzheimer’s disease in Europe: a collaborative study of 1980-1990 prevalence findings. Ann. Neurol. 30: 381–390, 1991.
Lobo A., Launer L.J., Fratiglioni L., Andersen K., Di Carlo A., Breteler M.M., Copeland J.R., Dartigues J-F., Jagger C., Martinez-Lage J.M., Soininen H., Hofman A.: Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 54 (Suppl. 5): S4-S9, 2000.
GAO/HEHS: Alzheimer’s disease: estimates of prevalence in the United States. Washington, United States General Accounting Office. Report GAO/HEHS-98-16, 1998.
Canadian Study of Health and Aging Working Group: Canadian Study of Health and Aging: study methods and prevalence of dementia. Can. Med. Assoc. J. 150: 899–913, 1994.
Evans D.A., Funkenstein H.H., Albert M.S., Scherr P.A., Cook N.R., Chown M.J., Hebert L.E., Hennekens C.H., Taylor J.O.: Prevalence of Alzheimer’s disease in a community population of older persons. Higher than previously reported. JAMA 262: 2551–2556, 1989.
Larrea F.A., Fisk J.D., Graham J.E., Stadnyk K.: Prevalence of cognitive impairment and dementia as defined by neuropsychological test performance. Neuroepidemiology 19: 121–129, 2000.
Hasegawa K.: The clinical issues of age-related dementia. Tohoku J. Exp. Med. 161 (Suppl.): 29–38, 1990.
Hasegawa K., Homma A., Sato H., Aoba A., Iwai Y., Yamaguchi N., Itami A.: The prevalence study of age-related dementia in the community. Geriatric Psychiatry 1: 94–105, 1984.
Jorm A.F.: Cross-national comparisons of the occurrence of Alzheimer’s and vascular dementias. Eur. Arch. Psychiatry Clin. Neurosci. 240: 218–222, 1991.
Wang W., Wu S., Cheng X., Dai H., Ross K., Du X., Yin W.: Prevalence of Alzheimer’s disease and other dementing disorders in an urban community of Beijing, China. Neuroepi-demiology 19: 194–200, 2000.
Liu H.C., Fuh J.L., Wang S.J., Liu C.Y., Larson E.B., Lin K.N., Wang H.C., Chou P., Wu Z.A., Lin C.H., Wang P.N., Teng E.L.: Prevalence and subtypes of dementia in a rural Chinese population. Alzheimer Dis. Assoc. Disord. 12: 127–134, 1998.
Nakajima K., Ueda Y., Kono I., Tanaka N., Mizuno T., Makino M., Iwamoto H., Mori S., Takanashi Y.: Prevalence of dementia and its subtypes in a rural area in Japan. Jap. J. Geriatrics 35: 530–534, 1998.
Bowen J.D., Malter A.D., Sheppard L., Kukull W.A., McCormick W.C., Teri L., Larson E.B.: Predictors of mortality in patients diagnosed with probable Alzheimer’s disease. Neurology 47: 433–439, 1996.
Østbye T., Hill G., Steenhuis R.E.: Mortality in elderly Canadians with and without dementia: a 5-year follow-up. Neurology 53: 521–526, 1999.
Østbye T., Steenhuis R.E., Wolfson C., Walton R., Hill G.: Predictors of five-year mortality in older Canadians: the Canadian Study of Health and Aging. J. Am. Geriatr. Soc. 47: 1–6, 1999.
Andersen K., Lolk A., Nielsen H., Andersen J., Olsen C., Kragh-Sörensen P.: Prevalence of very mild to severe dementia in Denmark. Acta Neurol. Scand. 96: 82–87, 1997.
Sternberg S.A., Wolfson C., Baumgarten M.: Undetected dementia in community-dwelling older people: the Canadian Study of Health and Aging. J. Am. Geriatr. Soc. 48: 1430–1434, 2000.
Ryan D.H.: Age-specific hospital incidence rates in dementia. A record linkage study of first-admission rates to Scottish hospitals (1968-1987). Dementia 5: 29–35, 1994.
Kokmen E., Chandra V., Schoenberg B.S.: Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960-1974. Neurology 38: 975–980, 1988.
Schoenberg B.S., Kokmen E., Okazaki H.: Alzheimer’s disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann. Neurol. 22: 724–729, 1987.
Bickel H., Cooper B.: Incidence and relative risk of dementia in an urban elderly population: findings of a prospective field study. Psychol. Med. 24: 179–192, 1994.
O’Connor D.W., Pollitt P.A., Hyde J.B., Fellows J.L., Miller N.D., Brook C.P.B., Reiss B.B., Roth M.: The prevalence of dementia as measured by the Cambridge Mental Disorders of the Elderly Examination. Acta Psychiatr. Scand. 79: 190–198, 1989.
Nilsson L.V.: Incidence of severe dementia in an urban sample followed from 70 to 79 years of age. Acta Psychiatr. Scand. 70: 478–486, 1984.
Hagnell O., Öjesjö L., Rorsman B.: Incidence of dementia in the Lundby Study. Neuroepidemiology 11 (Suppl. 1): 61–66, 1992.
Aevarsson O., Skoog I.: A population-based study on the incidence of dementia disorders between 85 and 88 years of age. J. Am. Geriatr. Soc. 44: 1455–1460, 1996.
Fratiglioni L., Viitanen M., von Strauss E., Tontodonati V., Herlitz A., Winblad B.: Very old women at highest risk of dementia and Alzheimer’s disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 48: 132–138, 1997.
Mölsä P.K., Marttila R.J., Rinne U.K.: Epidemiology of dementia in a Finnish population. Acta Neurol. Scand. 65: 541–552, 1982.
Fichter M.M., Schröppel H., Meller I.: Incidence of dementia in a Munich community sample of the oldest old. Eur. Arch. Psychiatry Clin. Neurosci. 246: 320–328, 1996.
Morgan K., Lilley J.M., Arie T., Byrne E.J., Jones R., Waite J.: Incidence of dementia in a representative British sample. Br. J. Psychiatry 163: 467–470, 1993.
Copeland J.R.M., Davidson I.A., Dewey M.E., Gilmore C., Larkin B.A., McWilliam C., Saunders P.A., Scott A., Sharma V., Sullivan C.: Alzheimer’s disease, other dementias, depression and pseudo-dementia: prevalence, incidence and three-year outcome in Liverpool. Br. J. Psychiatry 161: 230–239, 1992.
Copeland J.R.M., Dewey M.E., Davidson I.A., Saunders P.A., Scott A.: Geriatric Mental State-AGECAT: prevalence, incidence and long-term outcome of dementia and organic disorders in the Liverpool study of continuing health in the community. Neuroepidemiology 11 (Suppl.1): 84–87, 1992.
Clarke D., Morgan K., Lilley J., Arie T., Jones R., Waite J., Prettyman R.: Dementia and ‘borderline dementia’ in Britain: 8–year incidence and post–screening outcomes. Psychol. Med. 26: 829–835, 1996.
Paykel E.S., Brayne C., Huppert F.A., Gill C., Barkley C., Gehlhaar E., Beardsall L., Girling D.M., Pollitt P., O’Connor D.: Incidence of dementia in a population older than 75 years in the United Kingdom. Arch. Gen. Psychiatry 51: 325–332, 1994.
Brayne C., Gill C., Huppert F.A., Barkley C., Gehlhaar E., Girling D.M., O’Connor D.W., Paykel E.S.: Incidence of clinically diagnosed subtypes of dementia in an elderly population: Cambridge Project for Later Life. Br. J. Psychiatry 167: 255–262, 1995.
Ott A., Breteler M.B., van Harskamp F., Stijnen T., Hofman A.: Incidence and risk of dementia: the Rotterdam Study. Am. J. Epidemiol. 147: 574–580, 1998.
Letenneur L., Jacqmin H., Commenges D., Barberger-Gateau P., Dartigues J-F., Salamon R.: Cerebral and functional aging: first results on prevalence and incidence of the Paquid cohort. Meth. Inform. Med. 32: 249–251, 1993.
Letenneur L., Commenges D., Dartigues J-F., Barberger-Gateau P.: Incidence of dementia and Alzheimer’s disease in elderly community residents of south-western France. Int. J. Epidemiol. 23: 1256–1261, 1994.
Letenneur L., Gilleron V., Commenges D., Helmer C., Orgogozo J.M., Dartigues J-F.: Are sex and educational level independent predictors of dementia and Alzheimer’s disease? Incidence data from the PAQUID project. J. Neurol. Neu-rosurg. Psychiatry 66: 177–183, 1999.
Aronson M.K., Ooi W.L., Geva D.L., Masur D., Blau A., Frishman W.: Dementia: age-dependent incidence, prevalence, and mortality in the old old. Arch. Intern. Med. 151: 989–992, 1991.
Sayetta R.B.: Rates of senile dementia - Alzheimer’s type in the Baltimore longitudinal study. J. Chronic Dis. 39: 271–286, 1986.
Hebert L.E., Scherr P.A., Beckett L.A., Albert M.S., Pilgrim D.M., Chown M.F., Funkenstein H.H., Evans D.A.: Age-specific incidence of Alzheimer’s disease in a community population. JAMA 273: 1354–1359, 1995.
Bachman D.L., Wolf P.A., Linn R.T., Knoefel J.E., Cobb J.L., Belanger A.J., White L.R., D’Agostino R.B.: Incidence of dementia and probable Alzheimer’s disease in a general population: the Framingham Study. Neurology 43: 515–519, 1993.
Kokmen E., Beard C.M., O’Brien P.C., Offord K.P., Kurland L.T.: Is the incidence of dementing illness changing? A 25-year time trend study in Rochester, Minnesota (1960-1984). Neurology 43: 1887–1892, 1993.
Fillenbaum G.G., Heyman A., Huber M.S., Woodbury M.A., Leiss J., Schmader K.E., Bohannon A., Trapp-Moen B.: The prevalence and 3-year incidence of dementia in older black and white community residents. J. Clin. Epidemiol. 51: 587–595, 1998.
Kawas C., Brookmeyer R., Fozard J., Zonderman A.: Age-specific incidence rates of Alzheimer’s disease: the Baltimore Longitudinal Study of Aging. Neurology 54: 2072–2077, 2000.
Canadian Study of Health and Aging Working Group: The incidence of dementia in Canada. Neurology 55: 66–73, 2000.
Fukunishi I., Hayabara T., Hosokawa K.: Epidemiological surveys of senile dementia in Japan. Int. J. Soc. Psychiatry 37: 51–56, 1991.
Li G., Shen Y.C., Chen C.H., Zhau Y.W., Li S.R., Lu M.: A three-year follow-up study of age-related dementia in an urban area of Beijing. Acta Psychiatr. Scand. 83: 99–104, 1991.
Shen Y.C., Li G., Li Y.T., Chen C.H., Li S.R., Zhao Y.W., Zhang W.X.: Epidemiology of age-related dementia in China. Chin. Med. J. 107: 60–64, 1994.
Fratiglioni L., Launer L.J., Anderson K., Breteler M.M.B., Copeland J.R.M., Dartigues J-F., Lobo A., Martinez-Lage J.M., Soininen H., Hofman A.: Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 54 (Suppl. 5): S10-S15, 2000.
Jagger C., Clarke M., Anderson J.: Incidence of dementia in Melton Mowbray: a proposed study and its problems. Neuroepidemiology 11 (Suppl. 1): 57–60, 1992.
Martyn C.N., Pippard E.C.: Usefulness of mortality data in determining the geography and time trends of dementia. J. Epidemiol. Community Health 42: 134–137, 1988.
Raiford K., Anton-Johnson S., Haycox Z., Nolan K., Schaffer A., Caimano C., Fillenbaum G., Heyman A.: CERAD part VII: Accuracy of reporting dementia on death certificates of patients with Alzheimer’s disease. Neurology 44: 2208–2209, 1994.
Macera C.A., Sun R.K.P., Yeager K.K., Brandes D.A.: Sensitivity and specificity of death certificate diagnoses for dementing illnesses, 1988-1990. J. Am. Geriatr. Soc. 40: 479–481, 1992.
Jorm A.F., Korten A.E.: A method for calculating projected increases in the number of dementia sufferers. Aust. N.Z. J. Psychiatry 22: 183–189, 1988.
Brookmeyer R., Gray S.: Methods for projecting the incidence and prevalence of chronic diseases in aging populations: application to Alzheimer’s disease. Stat. Med. 19: 1481–1493, 2000.
Brookmeyer R., Gray S., Kawas C.: Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am. J. Public Health 88: 1337–1342, 1998.
van Duijn C.M.: Epidemiology of the dementias: recent developments and new approaches. J. Neurol. Neurosurg. Psychiatry 60: 478–488, 1996.
Hux M.J., O’Brien B.J., Iskedjian M., Goeree R., Gagnon M., Gauthier S.: Relation between severity of Alzheimer’s disease and costs of caring. Can. Med. Assoc. J. 159: 457–465, 1998.
Taylor D.H., Sloan F.A.: How much do persons with Alzheimer’s disease cost Medicare? J. Am. Geriatr. Soc. 48: 639–646, 2000.
Gutterman E.M., Markowitz J.S., Lewis B., Fillit H.: Cost of Alzheimer’s disease and related dementia in managed-medicare. J. Am. Geriatr. Soc. 47: 1065–1071, 1999.
Tomlinson B.E., Blessed G., Roth M.: Observations on the brains of nondemented old people. J. Neurol. Sci. 7: 287–307, 1968.
Rosenberg R.N.: The molecular and genetic basis of AD: the end of the beginning. The 2000 Wartenberg lecture. Neurology 54: 2045–2054, 2000.
Brayne C., Calloway P.: Normal ageing, impaired cognitive function, and senile dementia of the Alzheimer’s type: a continuum. Lancet 1: 1265–1267, 1988.
Ebly E.M., Parhad I.M., Hogan D.B., Fung T.S.: Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging. Neurology 44: 1593–1600, 1994.
Ritchie K., Kildea D.: Is senile dementia “age-related” or “ageing-related”? Evidence from meta-analysis of dementia prevalence in the oldest old. Lancet 346: 931–934, 1995.
Hall K., Gureje O., Ogunniyi A., Hui S.L., Baiyewu O., Unverzagt F.W., Oluwole S., Hendrie H.C.: Risk factors and Alzheimer’s disease: a comparative study of two communities. Aust. N.Z. J. Psychiatry 32: 698–706, 1998.
Carney J.M.: Oxidative stress leading to loss of critical proteases in Alzheimer’s disease: an alternative view of the etiology of AD. Ann. N.Y. Acad. Sci. 924: 160–163, 2000.
Henderson A.S.: Epidemiology of dementia disorders. Adv. Neurol. 51: 15–25, 1990.
Rocca W.A., van Duijn C.M., Clayton D., Chandra V., Fratiglioni L., Graves A.B., Heyman A., Jorm A.F., Kokmen E., Kondo K., Mortimer J.A., Shalat S.L., Soininen H., Hofman A.: Maternal age and Alzheimer’s disease: a collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20 (Suppl. 2): S21-S27, 1991.
van Duijn C.M., Hofman A.: Risk factors for Alzheimer’s disease: The EURODEM collaborative re-analysis of case-control studies. Neuroepidemiology 11 (Suppl. 1): 106–113, 1992.
Sulkava R., Wikström J., Aromaa A., Raitasalo R., Lehtinen V., Lahtela K., Palo J.: Prevalence of severe dementia in Finland. Neurology 35: 1025–1029, 1985.
Bachman D.L., Wolf P.A., Linn R., Knoefel J.E., Cobb J., Belanger A., D’Agostino R.B., White L.R.: Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 42: 115–119, 1992.
Weissman M.M., Myers J.K., Tischler G.L., Holzer C.E.III., Leaf P.J., Orvaschel H., Brody J.A.: Psychiatric disorders (DSM-III) and cognitive impairment among the elderly in a U.S. urban community. Acta Psychiatr. Scand. 71: 366–379, 1985.
McGonigal G., Thomas B., McQuade C., Starr J.M., MacLennan W.J., Whalley L.J.: Epidemiology of Alzheimer’s presenile dementia in Scotland, 1974-88. BMJ 306: 680–683, 1993.
Roelands M., Baro F., Dom H., Wostyn P.: Epidemiology research on dementia in Antwerp, Belgium. Neuroepidemiology 11 (Suppl. 1): 48–51, 1992.
Gussekloo J., Heeren T.J., Izaks G.J., Ligthart G.J., Rooijmans H.G.: A community based study of the incidence of dementia in subjects aged 85 years and over. J. Neurol. Neu-rosurg. Psychiatry 59: 507–510, 1995.
Bettini R., Gobbi G., Landonio M., Vezzetti V.: Epidemiology of pathological cerebral impairment. Clin. Ther. 140: 225–233, 1992.
Shaji S., Promodu K., Abraham T., Roy K.J., Verghese A.: An epidemiological study of dementia in a rural community in Kerala, India. Br. J. Psychiatry 168: 745–749, 1996.
Park J., Ko H.J., Park Y.N., Jung C.H.: Dementia among the elderly in a rural Korean community. Br. J. Psychiatry 164: 796–801, 1994.
Graves A.B., Larson E.B., Edland S.D., Bowen J.D., Mc-Cormick W.C., McCurry S.M., Rice M.M., Wenzlow A., Uomoto J.M.: Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington state. The Kame Project. Am. J. Epidemiol. 144: 760–771, 1996.
Prencipe M., Casini A.R., Ferretti C., Lattanzio M.T., Fiorel-li M., Culasso F.: Prevalence of dementia in an elderly rural population: effects of age, sex, and education. J. Neurol. Neu-rosurg. Psychiatry 60: 628–633, 1996.
Prineas R.J., Demirovic J., Bean J.A., Duara R., Gomez-Marin O., Loewenstein D., Sevush S., Stitt F., Szapocznik J.: South Florida Program on Aging and Health. Assessing the prevalence of Alzheimer’s disease in three ethnic groups. J. Florida Med. Assoc. 82: 805–810, 1995.
Breitner J.C., Wyse B.W., Anthony J.C., Welsh-Bohmer K.A., Steffens D.C., Norton M.C., Tschanz J.T., Plassman B.L., Meyer M.R., Skoog I., Khachaturian A.: APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology 53: 321–331, 1999.
Alpérovitch A., Berr C.: Risk factors of Alzheimer’s disease. Epidemiologic approach [French]. Bulletin de l’Academie Nationale de Medecine 180: 1673–1680, 1996.
van Duijn C.M., Clayton D., Chandra V., Fratiglioni L., Graves A.B., Heyman A., Jorm A.F., Kokmen E., Kondo K., Mortimer J.A., Rocca W.A., Shalat S.L., Soininen H., Hofman A.: Familial aggregation of Alzheimer’s disease and related disorders: a collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20 (Suppl. 2): S13-S20, 1991.
Breitner J.C., Gatz M., Bergem A.L., Christian J.C., Mortimer J., McClearn G.E., Heston L.L., Welsh K.A., Anthony J.C., Folstein M.F.: Use of twin cohorts for research in Alzheimer’s disease. Neurology 43: 261–267, 1993.
Raiha I., Kaprio J., Koskenvuo M., Rajala T., Sourander L.: Alzheimer’s disease in Finnish twins. Lancet 347: 573–578, 1996.
Bergem A.L., Engedal K., Kringlen E.: The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study. Arch. Gen. Psychiatry 54: 264–270, 1997.
Breitner J.C., Murphy E.A.: Twin studies of Alzheimer disease: II. Some predictions under a genetic model. Am. J. Med. Genet. 44: 628–634, 1992.
Breitner J.C., Welsh K.A.: Genes and recent developments in the epidemiology of Alzheimer’s disease and related dementia. Epidemiol. Rev. 17: 39–47, 1995.
Lannfelt L., Pedersen N.L., Lilius L., Axelman K., Johansson K., Viitanen M., Gatz M.: Apolipoprotein epsilon 4 allele in Swedish twins and siblings with Alzheimer disease. Alzheimer Dis. Assoc. Disord. 9: 166–169, 1995.
Roses A.D.: Apolipoprotein E alleles as risk factors in Alzheimer’s disease. Annu. Rev. Med. 47: 387–400, 1996.
Corder E.H., Saunders A.M., Risch N.J., Strittmatter W.J., Schmechel D.E., Gaskell P.C.J., Rimmler J.B., Locke P.A., Conneally P.M., Schmader K.E.: Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7: 180–184, 1994.
Buttini M., Akeefe H., Lin C., Mahley R.W., Pitas R.E., Wyss-Coray T., Mucke L.: Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neu-rodegenerative disease. Neurosci. 97: 207–210, 2000.
Graham D.I., Horsburgh K., Nicoll J.A., Teasdale G.M.: Apolipoprotein E and the response of the brain to injury. Ac-ta Neurochirur. (Suppl.) 73: 89–92, 1999.
Farrer L.A., Cupples A., Haines J.L.: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. JAMA 278: 1349–1356, 1997.
Weiner M.F., Vega G., Risser R.C., Honig L.S., Cullum C.M., Crumpacker D., Rosenberg R.N.: Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer’s disease. Biol. Psychiatry 45: 633–638, 1999.
Small B.J., Graves A.B., McEvoy C.L., Crawford F.C., Mullan M., Mortimer J.A.: Is APOE-epsilon4 a risk factor for cognitive impairment in normal aging? Neurology 54: 2082–2088, 2000.
Brayne C., Harrington C.R., Wischik C.M., Huppert F.A., Chi L.Y., Xuereb J.H., O’Connor D.W., Paykel E.S.: Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population. Dementia 7: 169–174, 1996.
Tierney M.C., Szalai J.P., Snow W.G., Fisher R.H., Tsuda T., Chi H., McLachlan D.R., St.George-Hyslop P.H.: A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment. Neurology 46: 149–154, 1996.
Jarvik G.P., Wijsman E.M., Kukull W.A., Schellenberg G.D., Yu C., Larson E.B.: Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer’s disease: a case-control study. Neurology 45: 1092–1096, 1995.
Sahota A., Yang M., Gao S., Hui S.L., Baiyewu O., Guerje O., Oluwole S., Ogunniyi A., Hall K.S., Hendrie H.C.: Apolipoprotein E-associated risk for Alzheimer’s Disease in the African-American population is genotype dependent. Ann. Neurol. 42: 659–661, 1997.
Osuntokun B.O., Sahota A., Ogunniyi A.O., Gureje O., Baiyewu O., Adeyinka A., Oluwole S.O., Komolafe O., Hall K.S., Unverzagt F.W., Hui S.L., Yang M., Hendrie H.C.: Lack of an association between Apolipoprotein E 4 and Alzheimer’s Disease in elderly Nigerians. Ann. Neurol. 38: 463–465, 1995.
Maestre G., Ottman R., Stern Y., Gurland B., Chun M., Tang M., Shelanski M., Tycko B., Mayeux R.: Apolipoprotein E and Alzheimer’s disease: ethnic variation in genotypic risks. Ann. Neurol. 37: 254–259, 1995.
Mayeux R., Ottman R., Maestre G., Ngai C., Tang M., Ginsberg H., Chun M., Tycko B., Shelanski M.: Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer’s disease. Neurology 45: 555–557, 1995.
Tang M., Maestre G., Tsai W.Y., Liu X.H., Feng L., Chung W.Y., Chun M., Schofield P., Stern Y., Tycko B., Mayeux R.: Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer’s disease. Ann. N.Y. Acad. Sci. 802: 6–15, 1996.
Yaffe K., Haan M., Byers A., Tangen C., Kuller L.: Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology 54: 1949–1953, 2000.
Ott A., Stolk R.P., Hofman A., van H.F., Grobbee D.E., Breteler M.M.: Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 39: 1392–1397, 1996.
Stewart R., Prince M., Mann A.: Vascular risk factors and Alzheimer’s disease. Aust. N.Z. J. Psychiatry 33: 809–813, 1999.
Hachinski V., Munoz D.: Vascular factors in cognitive impairment - where are we now? Ann. N.Y. Acad. Sci. 903: 1–5, 2000.
Emery V.O., Gillie E.X., Smith J.A.: Interface between vascular dementia and Alzheimer syndrome: nosologic redefinition. Ann. N.Y. Acad. Sci. 903: 229–238, 2000.
Notkola I.L., Sulkava R., Pekkanen J., Erkinjuntti T., Ehnholm C., Kivinen P., Tuomilehto J., Nissinen A.: Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer’s disease. Neuroepidemiology 17: 14–20, 1998.
Bonarek M., Baberger-Gateau P., Letenneur L., Deschamps V., Iron A., Dubroca B., Dartigues J-F.: Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the PAQUID study. Neuroepi-demiology 19: 141–148, 2000.
Jorm A.F., van Duijn C.M., Chandra V., Fratiglioni L., Graves A.B., Heyman A., Kokmen E., Kondo K., Mortimer J.A., Rocca W.A., Shalat S.L., Soininen H., Hofman A.: Psychiatric history and related exposures as risk factors for Alzheimer’s disease: a collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20 (Suppl. 2): S43-S47, 1991.
Jorm A.F.: Is depression a risk factor for dementia or cognitive decline? A review. Gerontology 46: 219–227, 2000.
Roberts G.W., Gentleman S.M., Lynch A.: Beta-amyloid protein deposition in the brain after severe head injury. J. Neurol. Neurosurg. Psychiatry 57: 419–425, 1994.
Horsburgh K., Cole G.M., Yang F., Savage M.J., Greenberg B.D., Gentleman S.M., Graham D.I., Nicoll J.A.: beta-amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury. Neuropathol. Appl. Neurobiol. 26: 124–132, 2000.
Graham D.I., Gentleman S.M., Nicoll J.A., Royston M.C., McKenzie J.E., Roberts G.W., Griffin W.S.: Altered be-ta-APP metabolism after head injury and its relationship to the aetiology of Alzheimer’s disease. Acta Neurochirur. Suppl. 66: 96–102, 1996.
Mortimer J.A., van Duijn C.M., Chandra V., Fratiglioni L., Graves A.B., Heyman A., Jorm A.F., Kokmen E., Kondo K., Rocca W.A., Shalat S.L., Soininen H., Hofman A.: Head trauma as a risk factor for Alzheimer’s disease: a collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20 (Suppl. 2): S28-S35, 1991.
Rasmusson D.X., Brandt J., Martin D.B., Folstein M.F.: Head injury as a risk factor in Alzheimer’s disease. Brain Injury 9: 213–219, 1995.
van Duijn C.M., Tanja T.A., Haaxma R., Schulte W., Saan R.J., Lameris A.J., Antonides-Hendriks G., Hofman A.: Head trauma and the risk of Alzheimer’s disease. Am. J. Epidemiol. 135: 775–782, 1992.
O’Meara E.S., Kukull W., Sheppard L., Bowen J.D., McCormick W.C., Teri L., Pfanschmidt M., Thompson J.D., Schellenberg G.D., Larson E.B.: Head injury and risk of Alzheimer’s disease by Apolipoprotein E Genotype. Am. J. Epidemiol. 146: 373–384, 1997.
Chandra V., Kokmen E., Schoenberg B.S.: Head trauma with loss of consciousness as a risk factor for Alzheimer’s disease. Neurology 39: 1576–1578, 1989.
Schofield P.W., Tang M., Marder K., Bell K., Dooneief G., Chun M., Sano M., Stern Y., Mayeux R.: Alzheimer’s disease after remote head injury: an incidence study. J. Neurol. Neurosurg. Psychiatry 62: 119–124, 1997.
Nicoll J.A., Roberts G.W., Graham D.I.: Amyloid beta-protein, APOE genotype and head injury. Ann. N.Y. Acad. Sci. 777: 271–275, 1996.
Guo Z., Cupples L.A., Kurz A., Auerbach S.H., Volicer L., Chui H., Green R.C., Sadovnick A.D., Duara R., DiCarli C., Johnson K., Go R.C., Growdon J.H., Haines J.L., Kukull W.A.: Head injury and the risk of AD in the MIRAGE study. Neurology 54: 1316–1323, 2000.
Brayne C.: Research and Alzheimer’s disease: an epidemiological perspective. Psychol. Med. 23: 287–296, 1993.
Canadian Study of Health and Aging: The Canadian Study of Health and Aging: risk factors for Alzheimer’s disease in Canada. Neurology 44: 2073–2080, 1994.
Sobel E., Davanipour Z., Sulkava R., Erkinjuntti T., Wikström J., Henderson V.W., Buckwalter G., Bowman J.D., Lee P.J.: Occupations with exposure to electromagnetic fields: a possible risk factor for Alzheimer’s disease. Am. J. Epidemiol. 142: 515–524, 1995.
Sobel E., Dunn M., Davanipour Z., Qian Z., Chui H.C.: Elevated risk of Alzheimer’s disease among workers with likely electromagnetic field exposure. Neurology 47: 1477–1481, 1996.
Sobel E., Davanipour Z.: Electromagnetic field exposure may cause increased production of amyloid beta and eventually lead to Alzheimer’s disease. Neurology 47: 1594–1600, 1996.
Dunea G., Mahurkar S.D., Mamdani B., Smith E.C.: Role of aluminum in dialysis dementia. Ann. Intern. Med. 88: 502–504, 1978.
Edwardson J.A.: The pathogenesis of cerebral beta-amyloid deposition and the possible role of aluminium. In: Lord Walton of Detchant (Ed.), Alzheimer’s disease and the environment. Royal Society of Medicine Sciences, London, 1991, pp. 24-34.
Lord Walton: Chairman’s conclusions. In: Lord Walton of Detchant (Ed.), Alzheimer’s disease and the environment. Royal Society of Medicine Sciences, London, 1991, pp. 163-166.
Still C.N., Kelley P.: On the incidence of primary degenerative dementia vs water fluoride content in South Carolina. Neurotoxicology 4: 123–131, 1980.
Martyn C.N., Barker D.J.P., Osmond C., Harris E.C., Edwardson J.A., Lacey R.F.: Geographical relation between Alzheimer’s disease and aluminium in drinking water. Lancet 1: 59–62, 1989.
Vogt T.: Water quality and health: study of a possible relationship between aluminium in drinking water and age-related dementia. Statistik Sentralbyra, Oslo-Kongsvinger, Norway, 1986.
Wettstein A., Aeppli J., Gautschi K., Peters M.: Failure to find a relationship between mnestic skills of octogenarians and aluminum in drinking water. Int. Arch. Occup. Environ. Health 63: 97–103, 1991.
Jacqmin H., Commenges D., Letenneur L., Barberger-Gateau P., Dartigues J-F.: Components of drinking water and risk of cognitive impairment in the elderly. Am. J. Epidemiol. 139: 48–57, 1994.
Jacqmin-Gadda H., Commenges D., Letenneur L., Dartigues J-F.: Silica and aluminum in drinking water and cognitive impairment in the elderly. Epidemiology 7: 281–285, 1996.
Rondeau V., Commenges D., Jacqmin-Gadda H., Dartigues J-F.: Relation between aluminum concentrations in drinking water and Alzheimer’s disease: an 8-year follow-up study. Am. J. Epidemiol. 152: 59–66, 2000.
Forbes W.F., Hill G.: The link between aluminum and Alzheimer’s disease. Mature Medicine March/April: 38–41, 1998.
Rifat S.L., Eastwood M.R., Crapper McLachlan D.R., Corey P.N.: Effect of exposure of miners to aluminium powder. Lancet 336: 1162–1165, 1990.
Graves A.B., White E., Koepsell T.D.: The association between aluminum-containing products and Alzheimer’s disease. J. Clin. Epidemiol. 43: 35–44, 1990.
Heyman A., Wilkinson W.E., Stafford J.A., Helms M.J., Sigmon A.H., Weinberg T.: Alzheimer’s disease: a study of epidemiological aspects. Ann. Neurol. 15: 335–341, 1984.
Amaducci L.A., Fratiglioni L., Rocca W.A., Fieschi C., Livrea P., Pedone D., Bracco L.: Risk factors for clinically diagnosed Alzheimer’s disease: a case-control study of an Italian population. Neurology 36: 922–931, 1986.
Broe G.A., Henderson A.S., Creasy H., McCusker E., Korten A.E., Jorm A.F., Longley W., Anthony J.C.: A case-control study of Alzheimer’s disease in Australia. Neurology 40: 1698–1707, 1990.
McLachlan D.R.C., Dalton A.J., Kruck T.P.A.: Intramuscular desferrioxamine in patients with Alzheimer’s disease. Lancet 337: 1304–1308, 1991.
Beard C.M., Kokmen E., Offord K.P., Kurland L.T.: Lack of association between Alzheimer’s disease and education, occupation, marital status, or living arrangement. Neurology 42: 2063–2068, 1992.
Fratiglioni L., Grut M., Forsell Y., Viitanen M., Grafström M., Holmën K., Ericsson K., Bäckman L., Ahlbom A., Winblad B.: Prevalence of Alzheimer’s disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 41: 1886–1892, 1991.
Knoefel J.E., Wolf P.A., Linn R.T.: Education has no effect on incidence of dementia and Alzheimer’s disease in the Framingham study. Neurology 41 (Suppl. 1): 322–333, 1991.
Zhang M., Katzman R., Salmon D., Jin H., Cai G., Wang Z., Qu G., Grant I., Yu E., Levy P., Klauber M.R., Liu W.T.: The prevalence of dementia and Alzheimer’s disease (AD) in Shanghai, China: impact of age, gender, and education. Ann. Neurol. 27: 428–437, 1990.
Dartigues J-F., Gagnon M., Michel P.: Le programme de recherche Paquid sur l’épidémiologie de la démence: méthodes et résultats initiaux. Rev. Neurol. (Paris) 147: 225–230, 1991.
Friedland R.P.: Epidemiology, education, and the ecology of Alzheimer’s disease. Neurology 43: 246–249, 1993.
Ott A., Breteler M.M.B., van Harskamp F., Claus J.J., van der Cammen T.J., Grobbee D.E., Hofman A.: Prevalence of Alzheimer’s disease and vascular dementia: association with education. The Rotterdam study. BMJ 310: 970–973, 1995.
Bonaiuto S., Rocca W.A., Lippi A.: Impact of education and occupation on prevalence of Alzheimer’s disease (AD) and multi-infarct dementia (MID) in Appignano, Macerata Province, Italy. Neurology 40 (Suppl. 1): 346, 1990.
Hagnell O., Franck A., Grasbeck A., Ohman R., Otterbeck L., Rorsman B.: Senile dementia of the Alzheimer type in the Lundby Study. II. An attempt to identify possible risk factors. Eur. Arch. Psychiatry Clin. Neurosci. 241: 231–235, 1992.
Katzman R.: Education and the prevalence of dementia and Alzheimer’s disease. Neurology 43: 13–20, 1993.
Dartigues J-F., Gagnon M., Mazaux J.M., Barberger-Gateau P., Commenges D., Letenneur L., Orgogozo J.M.: Occupation during life and memory performance in nondemented French elderly community residents. Neurology 42: 1697–1701, 1992.
Brenner D.E., Kukull W.A., van Belle G., Bowen J.D., McCormick W.C., Teri L., Larson E.B.: Relationship between cigarette smoking and Alzheimer’s disease in a population-based case-control study. Neurology 43: 293–300, 1993.
Graves A.B., van Duijn C.M., Chandra V., Fratiglioni L., Hey-man A., Jorm A.F., Kokmen E., Kondo K., Mortimer J.A., Rocca W.A., Shalat S.L., Soininen H., Hofman A.: Alcohol and tobacco consumption as risk factors for Alzheimer’s disease: a collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20 (Suppl. 2): S48-S57, 1991.
Letenneur L., Dartigues J-F., Commenges D., Barberger-Gateau P., Tessier J.F., Orgogozo J.M.: Tobacco consumption and cognitive impairment in elderly people. A population-based study Ann. Epidemiol. 4: 449–454, 1994.
van Duijn C.M., Hofman A.: Relation between nicotine intake and Alzheimer’s disease BMJ 302: 1491–1494, 1991.
Prince M., Cullen M., Mann A.: Risk factors for Alzheimer’s disease and dementia: a case-control study based on the MRC elderly hypertension trial Neurology 44: 97–104, 1994.
Wang H., Fratiglioni L., Frisoni G.B., Viitanen M., Winblad B.: Smoking and the occurrence of Alzheimer’s disease: cross-sectional and longitudinal data in a population-based study Am. J. Epidemiol. 149: 640–644, 1999.
Tyas S., Koval J.J., Pederson L.L.: Does an interaction between smoking and drinking influence the risk of Alzheimer’s disease? Results from three Canadian studies Stat. Med. 19: 1685–1696, 2000.
Nourhashémi F., Gillette-Guyonnet S., Andrieu S., Ghisolfi A., Ousset P.J., Grandjean H., Grand A., Pouls J., Vellas B., Albarede J.L.: Alzheimer disease: protective factors Am. J. Clin. Nutr. 71: 643S–649S, 2000.
Honjo H., Tanaka K., Kashiwagi T.: Senile dementia —Alzheimer’s type and estrogen Horm. Metab. Res. 27: 204–207, 1995.
Yaffe K., Sawaya G., Lieberburg I., Grady D.: Estrogen therapy in postmenopausal women: effects on cognitive function and dementia JAMA 279: 688–695, 1998.
Thomas T., Rhodin J.: Vascular actions of estrogen and Alzheimer disease Ann. N.Y. Acad. Sci. 903: 501–509, 2000.
Green P.S., Simpkins J.W.: Estrogens and estrogen-like non-feminizing compounds: their role in the prevention and treatment of Alzheimer’s disease Ann. N.Y. Acad. Sci. 924: 93–98, 2000.
Wang P.N., Liao S.Q., Liu R.S., Liu C.Y., Chao H.T., Lu S.R., Yu H.Y., Wang S.J., Liu H.C.: Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study Neurology 54: 2061–2066, 2000.
Mulnard R.A., Cotman C.W., Kawas C., van Dyck C.H., Sano M., Doody R., Koss E., Pfeiffer E., Jin S., Gamst A., Grundman M., Thomas R., Thal L.J.: Estrogen replacement therapy for treatment of mild to moderate Alzheimer Disease: a randomized controlled trial JAMA 283: 1007–1015, 2000.
Henderson V.W., Paganini-Hill A., Miller B.L., Elble R.J., Reyes P.F., Shoupe D., McCleary C.A., Klein R.A., Hake A.M., Farlow M.R.: Estrogen for Alzheimer’s disease in women: randomized, double-blind, placebo-controlled trial Neurology 54: 295–301, 2000.
Marder K., Sano M.: Estrogen to treat Alzheimer’s disease: too little, too late? Neurology 54: 2035–2037, 2000.
McGeer P.L., Schulzer M., McGeer E.G.: Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease: a review of 17 epidemiologic studies Neurology 47: 425–432, 1996.
Pasinetti G.M.: Cyclooxygenase and inflammation in Alzheimer’s disease: experimental approaches and clinical interventions J. Neurosci. Res. 54: 1–6, 1998.
Breitner J.C.S., Gau B.A., Welsh K.A., Plassman B.L., McDonald W.M., Helms M.J., Anthony J.C.: Inverse association of anti-inflammatory treatments and Alzheimer’s disease: Initial results of a cotwin control study Neurology 44: 227–232, 1994.
Stewart W.F., Kawas C., Corrada M., Metter E.J.: Risk of Alzheimer’s disease and duration of NSAID use Neurology 48: 626–632, 1997.
McGeer P.L., McGeer E., Rogers J., Sibley J.: Anti-inflammatory drugs and Alzheimer disease Lancet 335: 1037, 1990.
Rogers J., Kirby L.C., Hempelman S.R., Berry D.L., McGeer P.L., Kaszniak A.W., Zalinski J., Cofield M., Mansukhani L., Willson P.: Clinical trial of indomethacin in Alzheimer’s disease Neurology 43: 1609–1611, 1993.
Bruce-Jones P.N., Crome P., Kalra L.: Indomethacin and cognitive function in healthy elderly volunteers Br. J. Clin. Pharmacol. 38: 45–51, 1994.
Rosenberg R.N., Richter R.W., Risser R.C., Taubman K., Prado-Farmer I., Ebalo E., Posey J., Kingfisher D., Dean D., Weiner M.F., Svetlik D., Adams P., Honig L.S., Cullum C.M., Schaefer F.V.: Genetic factors for the development of Alzheimer disease in the Cherokee Indian Arch. Neurol. 53: 997–1000, 1996.
Hendrie H.C., Hall K.S., Pillay N., Rodgers D., Prince C., Norton J., Brittain H., Nath A., Blue A., Kaufert J.: Alzheimer’s disease is rare in Cree Int. Psychogeriatr. 5: 5–14, 1993.
Paganini-Hill A., Henderson V.W.: Estrogen replacement therapy and risk of Alzheimer disease Arch. Intern. Med. 156: 2213–2217, 1996.
Broe G.A., Creasey H., Jorm A.F., Bennett H.P., Casey B., Waite L.M., Grayson D.A., Cullen J.: Health habits and risk of cognitive impairment and dementia in old age: a prospective study on the effects of exercise, smoking and alcohol consumption Aust. N.Z. J. Public Health 22: 621–623, 1998.
Jaendel C., Nicolas M.B., Dubois E., Nabet-Belleville F., Penin F., Cuny G.: Lipid peroxidation and free radical scavengers in Alzheimer’s disease Gerontology 35: 275–282, 1989.
Carr D.B., Goate A., Phil D., Morris J.C.: Current concepts in the pathogenesis of Alzheimer’s disease Am. J. Med. 103: 1S–2S, 1997.
Diaz-Arrastia R.: Hyperhomocysteinemia: a new risk factor for Alzheimer disease? Arch. Neurol. 55: 1407–1408, 1998.
Clarke R., Smith A.D., Jobst K.A., Refsum H., Sutton L., Ueland P.M.: Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease Arch. Neurol. 55: 1449–1455, 1998.
Orgogozo J., Dartigues J-F., Lafont S., Letenneur L., Com-menges D., Salamon R.: Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area Rev. Neurol. (Paris) 153: 185–192, 1997.
Launer L.J., Feskens E.J.M., Kalmijn S., Kromhout D.: Smoking, drinking, and thinking. The Zutphen Elderly Study Am. J. Epidemiol. 143: 219–227, 1996.
Ruitenberg A., Swieten J.C., Hofman A., Breteler M.M.B.: Alcohol consumption and risk of dementia: results from the Rotterdam Study Neurobiol Aging 21 (Suppl. 1): S247, 2000.
Tredici G., Miloso M., Nicolini G., Galbiati S., Cavaletti G., Bertelli A.: Resveratrol, map kinases and neuronal cells: might wine be a neuroprotectant? Drugs Exp. Clin. Res. 25: 99–103, 1999.
Crawford J.G.: Alzheimer’s disease risk factors as related to